David Sanford, Hagop Kantarjian, Jeffrey Skinner, Elias Jabbour and Jorge Cortes (2015) “Phase II trial of ponatinib in patients with chronic myeloid leukemia resistant to one previous tyrosine kinase inhibitor”, Haematologica. Pavia, Italy, 100(12), pp. e494-e495. doi: 10.3324/haematol.2015.132845.